KUROS BIOSCIENCES
Kuros Biosciences AG is a Swiss-based company focused on the development of innovative products for tissue repair and regeneration. Founded in 2000 as a spin-off of the Eidgenรถssische Technische Hochschule Zรผrich (ETHZ), Kuros has developed a pipeline of products based upon its proprietary technology platforms. These platforms were developed from work carried out at ETHZ, at the University of Zรผrich and at the California Institute of Technology (CalTech). In addition, in early 2017 Kuros acq... uired Xpand Biotechnology to gain access to its MagnetOs family of bone graft substitutes and the associated surface science technology. Kuros has attractive commercial prospects in key market segments as well as an EU hub for future clinical and distribution operations. The company is in transition to commercial stage with one product having marketing approval in the EU and US and further product expected to achieve EU approval this year. MagnetOs is approved for sale in the EU for orthopedic, spine and dental applications, and in the US for posterolateral spinal fusion. In addition, a putty formulation is being prepared for submission in the EU and the US in the second half of this year. Neuroseal, a novel biomaterial for dural sealing, is Kurosโ second product and currently under review for CE marking in the EU. Kuros has also assembled a pipeline of clinical stage programs in various stages of development and amassed significant clinical and preclinical data in a number of indications and applications primarily in the area of orthobiologics. The Company has enrolled over 600 patients in multinational clinical trials, and has generated promising safety and efficacy in a number of significant indications.
KUROS BIOSCIENCES
Industry:
Biopharma Biotechnology Health Care Medical
Founded:
2000-01-01
Address:
Schlieren, Zurich, Switzerland
Country:
Switzerland
Website Url:
http://www.kuros.ch
Total Employee:
11+
Status:
Active
Contact:
41 44 200 56 00
Email Addresses:
[email protected]
Total Funding:
70.93 M USD
Technology used in webpage:
SPF Mobile Non Scaleable Content Hostpoint DNS EUKHost
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Arbutus Biopharma
Arbutus Biopharma Corporation is a publicly-traded biopharmaceutical company.
CeQur
CeQur develops and commercializes insulin delivery systems, giving people with type 2 diabetes freedom from multiple daily injections.
Edison Pharmaceuticals
Edison Pharmaceuticals develops medicines for the treatments of children and adults diagnosed with rare and neglected diseases.
EUCODIS Bioscience
EUCODIS Bioscience delivered high-performance enzyme solutions for applications in the chemical, cosmetics and pharmaceutical industries.
ExpreS2ion
ExpreS2ion Biotechnologies is a biotech company within protein production in Drosophila Schneider-2 (S2) cells.
Kinarus Therapeutics (SIX:KNRS)
Kinarus is focused on developing novel treatments for patients suffering from serious viral, respiratory, and ophthalmic diseases.
Lineage Cell Therapeutics
Lineage Cell Therapeutics is a clinical-stage biotechnology company developing novel cellular therapies to treat unmet medical needs.
Pharma Biozyme Lab
Pharma Biozyme Lab develops products that contribute to the decontamination and detoxification of the body.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2016-12-19 | Xpand Biotechnology | Xpand Biotechnology acquired by Kuros Biosciences | N/A |
Investors List
LifeCare Partners
LifeCare Partners investment in Post-IPO Equity - Kuros Biosciences
Life Sciences Partners
Life Sciences Partners investment in Post-IPO Equity - Kuros Biosciences
VI Partners
VI Partners investment in Post-IPO Equity - Kuros Biosciences
Omega Funds
Omega Funds investment in Post-IPO Equity - Kuros Biosciences
Swiss Helvetia Fund
Swiss Helvetia Fund investment in Post-IPO Equity - Kuros Biosciences
CDC Enterprises
CDC Enterprises investment in Post-IPO Equity - Kuros Biosciences
Neomed Management
Neomed Management investment in Post-IPO Equity - Kuros Biosciences
DEFI Gestion
DEFI Gestion investment in Post-IPO Equity - Kuros Biosciences
VINCI CAPITAL
VINCI CAPITAL investment in Post-IPO Equity - Kuros Biosciences
VI Partners
VI Partners investment in Post-IPO Equity - Kuros Biosciences
Official Site Inspections
http://www.kuros.ch
- Host name: 109.75.164.135
- IP address: 109.75.164.135
- Location: United Kingdom
- Latitude: 51.4964
- Longitude: -0.1224
- Timezone: Europe/London